Morgan Stanley’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.18M Sell
744,536
-413,160
-36% -$4.28M ﹤0.01% 3971
2025
Q4
$14.3M Buy
1,157,696
+628,821
+119% +$6.74M ﹤0.01% 3258
2025
Q3
$4.66M Sell
528,875
-204,505
-28% -$1.59M ﹤0.01% 4212
2025
Q2
$4.68M Sell
733,380
-133,087
-15% -$762K ﹤0.01% 4108
2025
Q1
$4.21M Sell
866,467
-360,518
-29% -$2.98M ﹤0.01% 4071
2024
Q4
$11.7M Buy
1,226,985
+3,964
+0.3% +$36.4K ﹤0.01% 3275
2024
Q3
$10.2M Sell
1,223,021
-19,116
-2% -$174K ﹤0.01% 3415
2024
Q2
$8.47M Sell
1,242,137
-51,565
-4% -$222K ﹤0.01% 3444
2024
Q1
$3.27M Sell
1,293,702
-1,177,010
-48% -$2.65M ﹤0.01% 4246
2023
Q4
$5.93M Buy
2,470,712
+1,860,672
+305% +$4.37M ﹤0.01% 4274
2023
Q3
$2.07M Buy
610,040
+26,770
+5% +$148K ﹤0.01% 4370
2023
Q2
$4.29M Buy
583,270
+81,025
+16% +$751K ﹤0.01% 3887
2023
Q1
$5.2M Sell
502,245
-151,499
-23% -$1.83M ﹤0.01% 3751
2022
Q4
$7.72M Buy
653,744
+326,175
+100% +$5.05M ﹤0.01% 3325
2022
Q3
$6.88M Sell
327,569
-372,534
-53% -$10.4M ﹤0.01% 3367
2022
Q2
$21.7M Buy
700,103
+262,451
+60% +$8.96M ﹤0.01% 2196
2022
Q1
$18M Buy
437,652
+190,845
+77% +$8.42M ﹤0.01% 2235
2021
Q4
$10.7M Sell
246,807
-48,777
-17% -$2.21M ﹤0.01% 2880
2021
Q3
$14.8M Sell
295,584
-166,947
-36% -$10.1M ﹤0.01% 2424
2021
Q2
$29.1M Buy
462,531
+241,936
+110% +$15.5M ﹤0.01% 1768
2021
Q1
$20.5M Buy
220,595
+63,201
+40% +$6.47M ﹤0.01% 1882
2020
Q4
$14.1M Buy
157,394
+128,357
+442% +$11.8M ﹤0.01% 2168
2020
Q3
$3M Sell
29,037
-111,724
-79% -$12M ﹤0.01% 3260
2020
Q2
$11.1M Buy
140,761
+15,714
+13% +$1.17M ﹤0.01% 1878
2020
Q1
$7.24M Sell
125,047
-103,251
-45% -$5.95M ﹤0.01% 2080
2019
Q4
$12.3M Buy
228,298
+68,785
+43% +$3.73M ﹤0.01% 2173
2019
Q3
$8.34M Sell
159,513
-111,256
-41% -$5.18M ﹤0.01% 2311
2019
Q2
$13.1M Buy
270,769
+185,660
+218% +$8.9M ﹤0.01% 1876
2019
Q1
$4.3M Sell
85,109
-106,348
-56% -$6.27M ﹤0.01% 2855
2018
Q4
$11.3M Sell
191,457
-62,711
-25% -$4.04M ﹤0.01% 1995
2018
Q3
$16.7M Buy
254,168
+78,700
+45% +$4.59M ﹤0.01% 1855
2018
Q2
$8.86M Buy
175,468
+29,091
+20% +$1.52M ﹤0.01% 2505
2018
Q1
$7.71M Sell
146,377
-118,508
-45% -$5.91M ﹤0.01% 2600
2017
Q4
$12.3M Buy
264,885
+110,079
+71% +$4.63M ﹤0.01% 2188
2017
Q3
$6.26M Buy
154,806
+45,862
+42% +$1.66M ﹤0.01% 2727
2017
Q2
$3.69M Sell
108,944
-2,573
-2% -$79.4K ﹤0.01% 3203
2017
Q1
$3.24M Sell
111,517
-42,363
-28% -$1.29M ﹤0.01% 3361
2016
Q4
$5.05M Buy
153,880
+123,467
+406% +$3.7M ﹤0.01% 2979
2016
Q3
$958K Sell
30,413
-608,226
-95% -$17.7M ﹤0.01% 4074
2016
Q2
$18M Buy
638,639
+505,942
+381% +$19.8M 0.01% 1503
2016
Q1
$4.82M Buy
132,697
+81,042
+157% +$2.86M ﹤0.01% 2565
2015
Q4
$2.07M Sell
51,655
-3,555
-6% -$124K ﹤0.01% 3457
2015
Q3
$1.57M Buy
55,210
+40,122
+266% +$1.32M ﹤0.01% 3728
2015
Q2
$498K Sell
15,088
-20,206
-57% -$626K ﹤0.01% 4711
2015
Q1
$1.01M Buy
35,294
+25,480
+260% +$731K ﹤0.01% 4121
2014
Q4
$266K Sell
9,814
-17,321
-64% -$413K ﹤0.01% 5072
2014
Q3
$578K Sell
27,135
-150,277
-85% -$3.44M ﹤0.01% 4472
2014
Q2
$3.98M Sell
177,412
-45,893
-21% -$1.07M ﹤0.01% 2879
2014
Q1
$5.64M Buy
223,305
+90,279
+68% +$2.28M ﹤0.01% 2477
2013
Q4
$3.06M Buy
+133,026
New +$2.77M ﹤0.01% 3038

Other funds holding EBS